CoChat

Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis

Kale‐Pradhan, Pramodini B., Jassaly, Harjot K., Wilhelm, Sheila M. · 2010 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 104

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Study Objective. To evaluate the efficacy of a Lactobacillus probiotic singleagent regimen in preventing antibiotic‐associated diarrhea (AAD). Design. Meta‐analysis of 10 randomized, blinded, placebo‐controlled trials. Patients. A total of 1862 pediatric and adult patients who received a Lactobacillus single‐agent regimen or placebo for the prevention of AAD. Measurements and Main Results. The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched from inception through May 2008 by two investigators independently using the following key words: probiotic, Lactobacillus, antibiotic‐associated diarrhea. Full reports published in English were included if the studies were randomized, blinded, and placebo‐controlled trials that evaluated the efficacy of Lactobacillus single‐agent regimens versus placebo in the prevention of AAD. Bibliographies of recent review articles and systematic reviews were hand searched. Quality of the studies was assessed by using the Jadad scoring system. Number of subjects, age, Lactobacillus regimen, follow‐up period, and occurrence of AAD were extracted into a standardized data collection form. Overall impact of Lactobacillus on AAD was compared with placebo by using a random‐effects model. Ten studies with a total of 1862 patients (50.4% male) met all criteria. Six studies included patients aged 18 years or older, whereas four included patients younger than 18 years (range 2 wks‐14 yrs). Jadad scores ranged from 2–5 (out of 5). The total daily dose of Lactobacillus ranged from 2 times 10 9 −4 times 10 10 colony‐forming units and was administered throughout the entire antibiotic treatment (5–14 days) for all patients. The follow‐up period varied from 2 days‐3 months after the end of the probiotic regimen. The combined risk ratio (RR) of developing AAD was significantly lower with Lactobacillus compared with placebo (RR 0.35, 95% confidence interval [CI] 0.19‐0.67). In a subgroup analysis, this held true for adults but not pediatric patients (RR 0.24, 95% CI 0.08‐0.75 and RR 0.44, 95% CI 0.18‐1.08, respectively). Conclusion. Administration of a Lactobacillus single‐agent regimen as a prophylactic agent during antibiotic treatment reduced the risk of developing AAD compared with placebo in adults but not pediatric patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.30.2.119

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 104

Metadata

Authors
Kale‐Pradhan, P. B., Jassaly, H. K., & Wilhelm, S. M.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2010-02
Volume
30
Issue
2
Pages
119-126
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2026139706
Cited by
104
References
7
FWCI
22.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis. https://app.cochat.ai/papers/10.1592/phco.30.2.119
The paper
Kale‐Pradhan, P. B., Jassaly, H. K., & Wilhelm, S. M. (2010). Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.30.2.119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.